Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

Clinical trial NCT06983964 · RECRUITING

Trial details

NCT number: NCT06983964
Sponsor: Beijing Boren Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Autoimmune Disease

Start date: 2025-02-20
Primary completion: 2027-02-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.